| Phase 11 trial |
|
Phase 1
|
NCT07321626 |
Jun 2025 → Dec 2027 expected |
acute myeloid leukemia, disease related to hematopoietic stem cell transplant, myelodysplastic syndrome |
First Affiliated Hospital of Zhejiang University |
Recruiting
|
No outcome recorded
|
| Phase 215 trials |
|
Phase 2
|
NCT07829952 |
Nov 2026 → Jun 2028 expected |
disease related to hematopoietic stem cell transplant, thrombocytopenia |
The First Affiliated Hospital of Henan University of Science and Technology |
Not yet recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT07532408 |
Jun 2026 → Dec 2028 |
aplastic anemia |
Peking Union Medical College Hospital |
Withdrawn
|
No outcome recorded
|
|
Phase 2
|
NCT07523009 |
Jun 2026 → Dec 2028 |
aplastic anemia |
Peking Union Medical College Hospital |
Withdrawn
|
No outcome recorded
|
|
Phase 2
|
NCT07400250 |
Apr → Oct 2026 expected |
autoimmune thrombocytopenia |
Peking Union Medical College Hospital |
Not yet recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT07558434 |
Apr 2026 → Dec 2028 expected |
aplastic anemia |
Peking Union Medical College Hospital |
Not yet recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT07572084 |
Apr 2026 → Dec 2028 expected |
aplastic anemia |
Peking Union Medical College Hospital |
Not yet recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT07043894 |
Dec 2025 → Sep 2026 overdue |
cancer, hematopoietic and lymphoid cell neoplasm, thrombocytopenia |
Cancer Institute and Hospital, Chinese Academy of Medical Sciences |
Recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT07586813 |
Dec 2025 → Oct 2027 expected |
colorectal cancer, malignant pancreatic neoplasm, thrombocytopenia |
Peking University People's Hospital |
Recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT07586826 |
Dec 2025 → Oct 2027 expected |
breast cancer, cervical cancer, fallopian tube cancer, non-small cell lung carcinoma +3 |
Peking University People's Hospital |
Recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT07128576 |
Sep 2025 → Aug 2027 expected |
cancer |
Zhujiang Hospital |
Not yet recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT07063225 |
Aug 2025 → Aug 2026 overdue |
thrombocytopenia |
Institute of Hematology & Blood Diseases Hospital, China |
Recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT06992128 |
May 2025 → Jan 2028 expected |
autoimmune thrombocytopenia |
Institute of Hematology & Blood Diseases Hospital, China |
Recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT06686927 |
Nov 2024 → Sep 2025 overdue |
autoimmune thrombocytopenia |
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology |
Recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT06613880 |
Oct 2024 → Jan 2026 overdue |
aplastic anemia |
Institute of Hematology & Blood Diseases Hospital, China |
Recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT06658834 |
Jun 2024 → Jun 2025 overdue |
autoimmune thrombocytopenia |
Institute of Hematology & Blood Diseases Hospital, China |
Recruiting
|
No outcome recorded
|
|
| Phase 32 trials |
|
Phase 3
|
NCT07345000 |
Jan 2026 → Oct 2029 expected |
idiopathic aplastic anemia |
Qilu Pharmaceutical Co., Ltd. |
Not yet recruiting
|
No outcome recorded
|
|
Phase 3
|
NCT06440824 |
Jun 2024 → Jun 2025 |
thrombocytopenia |
Shandong University |
Unknown
|
No outcome recorded
|
| Phase not applicable2 trials |
| — |
NCT07206823 |
Sep 2025 → Feb 2027 expected |
autoimmune thrombocytopenia |
The First Affiliated Hospital of Soochow University |
Recruiting
|
No outcome recorded
|
| — |
NCT07185893 |
Sep 2025 → Mar 2028 expected |
cancer, thrombocytopenia |
Jun Wang |
Not yet recruiting
|
No outcome recorded
|